Comparison between idiopathic achalasia and achalasia caused by Chagas' disease: a review about the pathophysiology of the diseases. AIMS: We performed a review of papers with results about the pathophysiology and esophageal motility alterations in idiopathic achalasia and Chagas' disease. The results of the studies of the effects of atropine, edrophonium and botulin toxin suggested that the excitatory innervation is more intensely impaired in Chagas' disease than in idiopathic achalasia, explaining the increase in the lower esophageal sphincter pressure found in achalasia. The patients with Chagas' disease have more circulating muscarinic cholinergic receptor M2 autoantibodies than patient with idiopathic achalasia.
|Published (Last):||17 July 2006|
|PDF File Size:||13.12 Mb|
|ePub File Size:||16.63 Mb|
|Price:||Free* [*Free Regsitration Required]|
Comparison between idiopathic achalasia and achalasia caused by Chagas' disease: a review about the pathophysiology of the diseases. AIMS: We performed a review of papers with results about the pathophysiology and esophageal motility alterations in idiopathic achalasia and Chagas' disease. The results of the studies of the effects of atropine, edrophonium and botulin toxin suggested that the excitatory innervation is more intensely impaired in Chagas' disease than in idiopathic achalasia, explaining the increase in the lower esophageal sphincter pressure found in achalasia.
The patients with Chagas' disease have more circulating muscarinic cholinergic receptor M2 autoantibodies than patient with idiopathic achalasia. The duration of the contractions in the esophageal body is longer in idiophatic achalasia than in Chagas' disease. Headings: Esophageal achalasia. Chagas disease. Esophageal motility disorders. Manometric study of esophageal body in idiopathic and Chagas' disease related achalasia - correlation with the degree of megaesophagus.
Recent advances in diseases of the esophagus. Bologna: Monduzzi; Upper esophageal sphincter and pharyngeal function in idiopathic and Chagas' disease related achalasia. Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia.
Gastroenterology ; Intrasphincteric botulinum toxin injection in the treatment of chagasic achalasia. Dis Esophagus ; Leber Magen Darm ; Role of gastrin supersensitivity in the pathogenesis of lower esophageal sphincter hypertension in achalasia.
J Clin Invest ; Alterations in normal esophageal motility in patients with Chagas' disease. Am J Dig Dis ; Dantas RO. Idiopathic achalasia and chagasic megaesophagus. J Clin Gastroenterol ; Effect of isosorbide dinitrate and atropine on the lower esophageal sphincter pressure in chagasic patients. Acta Physiol Pharmacol Latinoam ; Troncon LEA. Lower esophageal sphincter pressure in Chagas' disease. Dig Dis Sci ; Dysphagia in patients with Chagas' disease.
Dysphagia ; Esophageal manometric and radiologic findings in asymptomatic subjects with Chagas' disease. Arq Gastroenterol ; Upper esophageal sphincter pressure in patients with Chagas' disease and primary achalasia. Braz J Med Biol Res ; Esophageal motility of patients with Chagas' disease and idiopathic achalasia.
Esophageal striated muscle contractions in patients with Chagas' disease and idiopathic achalasia. Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia. Characterization of esophageal striated muscle in patients with achalasia.
Intraesophageal balloon distension test in Chagas' disease patients with noncardiac chest pain. Feldman M. Esophageal achalasia syndromes. Am J Med Sci ; Fonseca DN. Functional implications of circulating muscarinic cholinergic receptor autoantibodies in chagasic patients with achalasia.
A morphologic study of 42 resected specimens. Am J Surg Pathol ; Oesophageal tone in patients with achalasia.
Gut ; Functional anatomy and physiology of swallowing and esophageal motility. The esophagus. Heitmann P, Spinoza J. Oesophageal manometrics studies in patients with chronic Chagas' disease and megacolon.
Hirano I. Pathophysiology of achalasia. Curr Gastroenterol Rep ; Manometric heterogeneity in patients with idiopathic achalasia. Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia. Chagas' disease and Chagas' syndrome: the pathology of American trypanosomiasis. Adv Parasitol ; Alterations of the upper esophageal sphincter belch reflex in patients with achalasia.
Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest ; The cost-effectiveness of treatment strategies for achalasia. The spectrum of esophageal motor disorders in Chagas' disease. Am J Gastroenterol ; Gastrointestinal manifestations of Chagas' disease. Lower oesophageal sphincter response to pentagastrin in chagasic patients with megaoesophagus and megacolon.
Gut , Botulin toxin for achalasia: long-term outcome and predictors of response. Different neurotansmitter systems are involved in the development of esophageal achalasia.
Life Sci ; Fasting and food-stimulated plasma gastrin levels in chronic Chagas' disease. Digestion ; Plasma gastrin and gastric acid responses to insulin hypoglycemia in Chagas' disease. All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License. Services on Demand Journal. Rua Dr. How to cite this article.
Divertículo de Zenker
Recurrence after cardiomyotomy: diagnosis, technical options and results. AIM: To review the diagnosis, therapy and results in recurrent achalasia. RESULTS: Surgical options for treatment of relapsed megaesophagus are shown in forms so varied and personal with technical details and diverse. The techniques recommended were basically: remyotomy, cardioplasty, esophagectomy and mucosectomy, including variants of these operations. Headings: Esophageal achalasia.
Cómo comprender la dilatación esofágica
An update on esophageal perforation. Correspondencia a:. Esophageal perforation is a complicated clinical entity that demands a high level of diagnostic and therapeutic skills. The management alternatives vary from conservative treatment to esophagectomy, including primary suture and esophageal exclusion. This paper is a review of the literature and personal experience with this condition, focusing on etiology, clinical presentation, diagnostic workout, treatment, complications and mortality.
Síndrome de Mallory-Weiss
Daniel Sifrim R. Nimish Vakil EE. Anton LeMair Holanda. La gravedad de la disfagia tiende a asociarse con la gravedad del accidente cerebrovascular. La disfagia es un problema frecuente. Una de cada 17 personas presenta alguna forma de disfagia en el correr de su vida.
Aetna considers speech therapy for treatment of dysphagia, regardless of the presence of a communication disability, medically necessary for members who meet the criteria set forth below. Tenga en cuenta lo siguiente :Some plans limit coverage of medically necessary speech therapy services. Members should check their benefit plan descriptions for any applicable benefit plan limitations and exclusions on coverage for speech therapy services. Aetna considers esophageal dilation medically necessary for the treatment of symptomatic obstruction of the esophagus. Aetna considers esophageal dilation for the treatment of non-obstructive esophageal dysphagia experimental and investigational because its effectiveness has not been established.